Results 51 to 60 of about 1,551 (70)

JAK2 in Myeloproliferative Neoplasms: Still a Protagonist

Pharmaceuticals, 2022
Sara Christina Meyer
exaly  

Mutations, inflammation and phenotype of myeloproliferative neoplasms

Frontiers in Oncology, 2023
Sylvie Hermouet, Hermouet Sylvie
exaly  

Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms

International Journal of Molecular Sciences, 2021
Ernesto José Cuenca Zamora, Raúl Teruel-Montoya, Francisca Ferrer-Marin   +2 more
exaly  

Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study

American Journal of Respiratory and Critical Care Medicine, 2023
Pierre Thore, Étienne-Marie Jutant, Olivier Sitbon   +2 more
exaly  

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Histopathology, 2021
Stefan Porubský, Maike Büttner-Herold, Carsten Sticht   +2 more
exaly  

Second Cancer Onset in Myeloproliferative Neoplasms: What, When, Why?

International Journal of Molecular Sciences, 2022
Francesco Albano, Francesco Albano, Antonella Zagaria   +2 more
exaly  

Cardiovascular Disease in Myeloproliferative Neoplasms

JACC: CardioOncology, 2022
Gabriela Hobbs, Peter Libby, Orly Leiva   +2 more
exaly  

The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders

British Journal of Haematology, 2021
Nicholas Cross, Adam Mead, Catherine Cargo   +2 more
exaly  

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms

Cancers, 2021
Francesc Sole, Pamela Acha, Laura Palomo Sanchís   +2 more
exaly  

Aetiology of Myeloproliferative Neoplasms

Cancers, 2020
Mary Frances Mcmullin, Mcmullin Mary Frances   +1 more
exaly